STEPHANIE TAORMINA: Open Payments
NPI 1629487905 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 7 payments from 4 companies in 2025. Trend: 2023 $135 · 2024 $167 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| ABBVIE INC. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA.
Industry payments across MA — which companies pay providers there.
